Effect of Short-Term Postoperative Celecoxib Administration on Patient Outcome After Outpatient Laparoscopic Surgery

DSpace/Manakin Repository

Effect of Short-Term Postoperative Celecoxib Administration on Patient Outcome After Outpatient Laparoscopic Surgery

Show full item record


Title: Effect of Short-Term Postoperative Celecoxib Administration on Patient Outcome After Outpatient Laparoscopic Surgery
Author: Eng, Matthew R.
Abstract: Purpose: Non-opioid analgesics are increasingly used as part of a multimodal regimen for pain management. This prospective, randomized, double-blinded, placebo-controlled study was designed to evaluate the effect of short-term postoperative administration of celecoxib on pain management and recovery outcomes following laparoscopic surgery. Methods: Eighty consenting ASA I–III outpatients undergoing laparoscopic surgery were randomly assigned to one of two treatment groups: Control (placebo) or Celecoxib (celecoxib, 400 mg•day-1). The initial dose (celecoxib 400 mg or placebo po) was administered in the recovery room, and celecoxib 200 mg (or a placebo) po bid was continued for three additional days after surgery. Postoperative pain scores and the need for opioid-containing analgesics were recorded at specific intervals in the recovery room. Follow-up evaluations were performed at 24 hr, 48 hr, 72 hr and seven days and one month after surgery to assess post-discharge pain, analgesic requirements, complications, quality of recovery, and resumption of normal activities, as well as patient satisfaction with their pain management. Results: Celecoxib reduced mean pain scores and the need for analgesics at 24 hr and 48 hr postoperatively. Patient satisfaction with their postoperative pain management was also higher in the Celecoxib group (94 ± 8 vs 80 ± 25, P < 0.05). Quality of recovery scores were significantly higher in the Celecoxib group on the first and second postoperative days (17 ± 1 vs 15 ± 2, and 18 ± 1 vs 16 ± 2, respectively). Finally, bowel function recovered an average of one day earlier and patients resumed activities of daily living two days earlier in the Celecoxib group (P < 0.05). Conclusion: Short-term administration of celecoxib, 400 mg•day-1 po, decreased postoperative pain and the need for opioid-containing analgesic medication, leading to an improved quality of recovery after outpatient laparoscopic surgery. (Keywords: Celecoxib; anesthesiology; amubulatory; outpatient; NSAIDs; Cyclooxygenase-2; surgery; analgesia; Celebrex)
URI: http://hdl.handle.net/2152.5/922
Date: 2011-10-03

Files in this item

Files Size Format View Description
EngMatthew Abstract.docx 13.46Kb Microsoft Word 2007 View/Open Printable Abstract
EngMatthew.pdf 123.1Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record

Search DSpace


Advanced Search

Browse

My Account